News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
584,683 Results
Type
Article (33712)
Company Profile (157)
Press Release (550803)
Multimedia
Podcasts (137)
Webinars (26)
Section
Business (167552)
Career Advice (1907)
Deals (25975)
Drug Delivery (97)
Drug Development (71104)
Employer Resources (121)
FDA (13653)
Job Trends (11567)
News (282526)
Policy (25222)
Tag
2027 BioCapital Elite (1)
2027 BioMidwest Elite (1)
2027 Biotech Bay Standard (2)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (3)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (2200)
Academic (2)
Accelerated approval (32)
Adcomms (19)
Allergies (142)
Alliances (43305)
ALS (183)
Alzheimer's disease (1554)
Antibody-drug conjugate (ADC) (378)
Approvals (14095)
Artificial intelligence (602)
Autoimmune disease (237)
Automation (46)
Bankruptcy (205)
Best Places to Work (9498)
BIOSECURE Act (17)
Biosimilars (174)
Biotechnology (110)
Bladder cancer (169)
Brain cancer (65)
Breast cancer (657)
Cancer (5097)
Cardiovascular disease (413)
Career advice (1632)
Career pathing (42)
CAR-T (276)
CDC (39)
Celiac Disease (1)
Cell therapy (765)
Cervical cancer (37)
Clinical research (62262)
Collaboration (1920)
Company closure (4)
Compensation (1046)
Complete response letters (52)
COVID-19 (2100)
CRISPR (92)
C-suite (967)
Cystic fibrosis (136)
Data (6963)
Decentralized trials (3)
Denatured (49)
Depression (129)
Dermatology (61)
Diabetes (506)
Diagnostics (5330)
Digital health (44)
Diversity (9)
Diversity, equity & inclusion (37)
Drug discovery (306)
Drug pricing (151)
Drug shortages (26)
Duchenne muscular dystrophy (231)
Earnings (72991)
Editorial (56)
Employer branding (15)
Employer resources (111)
Events (96575)
Executive appointments (992)
FDA (16917)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (10)
Frontotemporal dementia (29)
Funding (1506)
Gene editing (186)
Generative AI (63)
Gene therapy (602)
GLP-1 (856)
Government (3467)
Grass and pollen (6)
Guidances (377)
Healthcare (14773)
HIV (69)
Huntington's disease (44)
IgA nephropathy (83)
Immunology and inflammation (223)
Immuno-oncology (83)
Indications (157)
Infectious disease (2379)
Inflammatory bowel disease (193)
Inflation Reduction Act (14)
Influenza (118)
Intellectual property (244)
Interviews (358)
IPO (12790)
IRA (42)
Job creations (2442)
Job search strategy (1348)
JPM (56)
Kidney cancer (15)
Labor market (67)
Layoffs (390)
Leadership (35)
Legal (5780)
Liver cancer (80)
Longevity (22)
Lung cancer (695)
Lymphoma (400)
Machine learning (47)
Management (40)
Manufacturing (836)
MASH (168)
Medical device (9951)
Medtech (10013)
Mergers & acquisitions (14310)
Metabolic disorders (1234)
mRNA (139)
Multiple sclerosis (170)
NASH (13)
Neurodegenerative disease (353)
Neuropsychiatric disorders (80)
Neuroscience (2846)
NextGen: Class of 2026 (4828)
Non-profit (3650)
Now hiring (38)
Obesity (536)
Opinion (274)
Ovarian cancer (180)
Pain (205)
Pancreatic cancer (224)
Parkinson's disease (329)
Partnered (27)
Patents (477)
Patient recruitment (575)
Peanut (49)
People (50674)
Pharmaceutical (43)
Pharmacy benefit managers (23)
Phase 1 (19251)
Phase 2 (27300)
Phase 3 (20640)
Pipeline (6996)
Policy (243)
Postmarket research (2346)
Preclinical (8111)
Press Release (59)
Prostate cancer (272)
Psychedelics (33)
Radiopharmaceuticals (287)
Rare diseases (889)
Real estate (4141)
Recruiting (51)
Regulatory (20313)
Reports (36)
Research institute (2117)
Resumes & cover letters (292)
Rett syndrome (33)
RNA editing (14)
RSV (72)
Schizophrenia (154)
Series A (257)
Series B (175)
Service/supplier (6)
Sickle cell disease (90)
Special edition (19)
Spinal muscular atrophy (137)
Sponsored (37)
Startups (2719)
State (1)
Stomach cancer (12)
Supply chain (96)
Tariffs (62)
The Weekly (87)
Vaccines (892)
Venture capital (76)
Weight loss (329)
Women's health (88)
Worklife (18)
Date
Today (104)
Last 7 days (516)
Last 30 days (2378)
Last 365 days (27842)
2026 (8285)
2025 (27980)
2024 (30669)
2023 (34075)
2022 (43577)
2021 (46459)
2020 (43778)
2019 (37257)
2018 (27807)
2017 (26666)
2016 (25664)
2015 (29991)
2014 (24462)
2013 (20824)
2012 (21231)
2011 (21459)
2010 (20254)
Location
Africa (696)
Alabama (91)
Alaska (6)
Arizona (204)
Arkansas (13)
Asia (34975)
Australia (5488)
California (11453)
Canada (3040)
China (1203)
Colorado (477)
Connecticut (520)
Delaware (368)
Europe (80495)
Florida (1607)
Georgia (369)
Hawaii (3)
Idaho (40)
Illinois (884)
India (78)
Indiana (526)
Iowa (22)
Japan (481)
Kansas (110)
Kentucky (38)
Louisiana (29)
Maine (43)
Maryland (1308)
Massachusetts (8434)
Michigan (308)
Minnesota (538)
Mississippi (5)
Missouri (110)
Montana (28)
Nebraska (22)
Nevada (118)
New Hampshire (54)
New Jersey (3164)
New Mexico (26)
New York (3014)
North Carolina (1432)
North Dakota (10)
Northern California (5698)
Ohio (344)
Oklahoma (23)
Oregon (35)
Pennsylvania (2207)
Puerto Rico (15)
Rhode Island (48)
South America (980)
South Carolina (51)
South Dakota (1)
Southern California (4575)
Tennessee (183)
Texas (1797)
United States (40257)
Utah (318)
Vermont (1)
Virginia (281)
Washington D.C. (79)
Washington State (906)
West Virginia (3)
Wisconsin (124)
Wyoming (2)
584,683 Results for "r and d biopharmaceuticals gmbh".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Career Advice
3 Career Moves R&D Professionals Must Make in a Skills-Based, AI-Driven Economy
As AI reshapes deeply specialized scientific work, R&D professionals must learn to navigate the shift to a skills-centered market. The key is knowing which skills to develop and how to leverage AI as scientific modalities evolve, technologies advance and regulatory complexity increases.
April 1, 2026
·
5 min read
·
Kenneth Munie
Press Releases
Akebia Therapeutics Appoints Biopharmaceutical Leader Philip Vickers, Ph.D. to its Board of Directors
April 2, 2026
·
5 min read
Press Releases
Angitia Biopharmaceuticals Announces $130 Million Series D Financing
February 5, 2026
·
4 min read
Press Releases
Insilico Medicine Announces Global R&D Collaboration with Lilly
March 30, 2026
·
2 min read
Press Releases
Veld Pharmaceuticals GmbH Announces Collaboration with Chiesi Farmaceutici S.p.A to Expand Access to Rare Disease Therapies Across Africa
April 14, 2026
·
1 min read
Press Releases
LB Pharmaceuticals Appoints R&D Biotech Executive Robert Lenz, M.D., Ph.D. to Board of Directors
March 9, 2026
·
4 min read
Press Releases
Cue Biopharma to Host Virtual R&D Day Event on April 7, 2026
March 26, 2026
·
8 min read
Press Releases
Mesoblast R&D Day Features Significant Commercial Progress & Platform Innovation
April 8, 2026
·
6 min read
Press Releases
Mesoblast to Host R&D Day on April 8, 2026
March 18, 2026
·
5 min read
Press Releases
Immunocore announces R&D leadership evolution
February 1, 2026
·
6 min read
1 of 58,469
Next
